Abstract
This study tests the hypothesis that Fluorescence Lifetime Imaging Microscopy (FLIM) of the endogenous metabolic co-enzymes (nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FAD)) provides insights into the metabolic signatures of CSCs and bulk tumor cells. By identifying and quantifying metabolic differences, researchers can potentially develop tailored therapies that address both CSCs and bulk tumor cells, improving therapeutic outcomes and addressing the challenges posed by tumor heterogeneity.
| Original language | English (US) |
|---|---|
| State | Published - 2024 |
| Event | 2024 Clinical and Translational Biophotonics, Translational 2024 - Part of Optica Biophotonics Congress: Biomedical Optic - Fort Lauderdale, United States Duration: Apr 7 2024 → Apr 10 2024 |
Conference
| Conference | 2024 Clinical and Translational Biophotonics, Translational 2024 - Part of Optica Biophotonics Congress: Biomedical Optic |
|---|---|
| Country/Territory | United States |
| City | Fort Lauderdale |
| Period | 4/7/24 → 4/10/24 |
ASJC Scopus subject areas
- Biomedical Engineering
- Biomaterials
- Electronic, Optical and Magnetic Materials
- Atomic and Molecular Physics, and Optics